Making a Differential Diagnosis

1.50 CME
1.50 CNE
90 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Making a Differential Diagnosis

Overview


Rare diseases are complicated and often not enough is known about these disorders that can have devastating health outcomes, high morbidity, and can impair quality of life. Lack of understanding about the disorder often leads to lengthy setbacks in diagnosis and is often misdiagnosed which leads to poor health consequences for patients. During this symposium, expert faculty will provide practical information for making the diagnosis of a rare disease and will be joined by a live patient speaker to discuss their journey to obtaining a proper diagnosis.

Provider Statement

Jointly_Accredited_Provider_PNGCME credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Support Statement

This activity is supported by educational funding provided by Amryt.


Target Audience

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians seeking to develop an expertise in clinical Lipidology.


Learning Objectives

At the Conclusion of this activity, participants should be able to:

  • Evaluate the management of complex patients with rare lipid disorders through case discussions.
  • Describe the mechanisms and manifestations of rare lipid disorders.
  • Identify treatment strategies for patients with rare lipid disorders.
  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

Faculty


Program Chair
Daniel E. Soffer, MD, FNLA

University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA


Zahid Ahmad, MD
Associate Professor of Internal Medicine
Lipid Section, Division of Endocrinology
UT Southwestern Medical Center
Dallas, TX


Elif A. Oral, MD, MS
Professor of Medicine
Metabolism, Endocrinology and Diabetes (MEND) Division
Department of Internal Medicine
Callwell Diabetes Institute
North Campus Research Complex
Ann Arbor, MI

Kathleen Wyne, MD, PhD, FNLA
Director, Adult Type 1 Diabetes Program
Director, Diabetes Transition of Care Clinic, OSU East Hospital
Professor, Clinical Medicine
Division of Endocrinology, Diabetes and Metabolism
Department of Internal Medicine
The Ohio State University Wexner Medical Center
Columbus, OH


Reviewer

Pamela Papp, ARNP, FNP-BC, FNLA
Lipid Specialist


Accreditation

abimSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Jointly_Accredited_Provider_PNGCME credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.

Pharmacist Accreditation Statement
Universal Activity Number – JA0007192-0000-23-024-H01-P (Application)
This Activity has been approved for 1.5 contact hour(s) (.150CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 1.5 contact hours. This continuing education activity offered 0.50 pharmacotherapy contact hours.


Credit Designation

Jointly_Accredited_Provider_PNGCME credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


How to Participate in this Activity and Obtain CME Credit

Statements of credit will be awarded based on the participant's completion and submission of the activity evaluation form. A statement of credit will be available for download upon completion of the online evaluation form. To receive credit, participants should complete the online course, score at least 30% on the post-test, and submit the evaluation. The deadline to claim credit is July 11, 2024.

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

IMPORTANT* Pharmacists MUST request credit before (60 days from the last day to claim credit). Credit requested after this date will be subject to a fee by the accreditation board.

For Dietitians: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities/ materials by CDR.


Disclosures

It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME.  All disclosures have been reviewed and resolved at this time.

Faculty reports the following relationship(s)

Zahid Ahmad, MD
Committee Member- Amryt

Elif A. Oral, MD, MS
Consultant- Amryt, Akcea, Ionis, Rhythm, Regeneron, Rejuvenate Bio
Contracted Research- Gemphire Therapeutics, Novo Nordisk

Daniel E. Soffer, MD, FNLA
Consultant- Novartis, Akcea, Regeneron
Contracted Research- Amgen, Amryt, AstraZeneca, Ionis/Akcea Therapeutics, Novartis, Regeneron, RegenXBio, Verve Therapeutics

Kathleen Wyne, MD, PhD, FNLA
Contracted Research- Intercept, Amryt

Reviewers report the following relationship(s)

NLA Staff reports no industry relationships.

Pamela Papp, ARNP, FNP-BC, FNLA reports no industry relationships.


Unlabeled and Investigational Usage

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Copyright Statement

The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.


CME Questions?

Questions about this CME activity may be sent to the National Lipid Association’s Continuing Medical Education Department at cme@lipid.org.